2Ishibashi Y, Matsumoto T, Niwa M, et al. CD147 and matrix metalloprotcinasc-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma [J]. Cancer, 2004,101 (9) : 1994 - 2000.
3Parsons SL, Watson SA, Collins HM, ct al. Gclatinase ( MMP-2 and MMP-9) expression in gastrointestinal malignancy[J]. Br J Cancer, 1998,78 ( 11 ) : 1495 - 1502.
4Sounni NE,Roghi C,Chabottaux V,et al. Up-rugulation of vascular endothelial growth factor-A by active membranetype matrix metalloproteinase through activation of Src-tyrosine kinase [ J ]. Biol Chcm, 2004,279 ( 14 ) : 13564 - 13574.
5Kanekura T, Chen X, Kanznki T. Bnsigin (CD147) is expressed ton melanoma cells and induces tumor cell invasion by stimulating production of matrix metaUoproteinases by fibroblasts[ J]. Int J Cancer,2002,99(5 ) :520 - 528.
6Tong PL, Mao TL, Chan WY, et al. Prognostic significance of stromalmctalloprotcinase-2 in ovarian adenocareinoma and its relation to carcinoma progression[ J ]. Gyneeol Oncol, 2004, 92 (2) : 559 -567.
7Mayr D,Kanitz V, Anderegg B, et al. Analysis of gcne amplification and prognostic markers in ovarian cancer using comparative genomie hybridization for microarray and immunohistochemical analysis for tissue microarrays[J]. Am J Clin Pathol, 2006,126 ( 1 ) : 101 - 109.
8Sun J,Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinases induce interactions [J]. Cancer Res ,2001,61 (5) :2276 - 2281.
9SillanpaaS,Anttila M,Suhonen K,et al. Prognostic significance of extracellular matrix mctalloproteinase inducer and matrix metaUoproteinase 2 in epithelial ovarian cancer[ J]. Tumour Biol,2007,28 (5) :280 - 289.
10Yan L,Zucker S,Toole BP.Roles of the multifunctional glycoprotein,emmprin (basigin; CD147),in tumour progression[J].Thromb Haemost,2005,93(2):199-204.
